STOCK TITAN

TILRAY BRANDS INC - TLRY STOCK NEWS

Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.

Overview

Tilray Brands Inc. stands as a globally recognized entity in the fields of medical cannabis, research, and consumer packaged goods. The company operates at the nexus of advanced medical cannabis research and the production of high-quality recreational and lifestyle products. With its GMP-certified facilities, Tilray ensures that patients, healthcare providers, and consumers alike receive products that adhere to rigorous standards of safety, consistency, and reliability.

Core Business and Operations

At its heart, Tilray Brands Inc. is dedicated to the development and supply of diversified cannabis products. Its portfolio spans a broad array of offerings including pharmaceutical-grade medical cannabis, innovative recreational solutions, hemp-based food products, and craft beverages. The company’s operational model is built on extensive research and production capabilities that underpin its commitment to wellness and therapeutic benefits. By embracing both science and artistry, Tilray continuously refines its quality control measures while deploying innovative practices in cultivation, extraction, and product development.

Market Position and Global Reach

Tilray Brands Inc. has established itself as a formidable player in a competitive global landscape. The company’s products are distributed across multiple continents, catering to diverse regulatory markets in Canada, Europe, Australia, Latin America, and selective regions of the United States. In particular, its prowess in medical cannabis is underscored by the company’s reputation as a reliable supplier to hospitals, pharmacies, and research institutions. The strategic export market further enhances its profile as a global leader in safe and effective cannabis treatment solutions.

Product Portfolio and Operational Excellence

The business model of Tilray is characterized by a dual approach: firstly, addressing the essential needs of patients through medical cannabis products, and secondly, engaging lifestyle consumers with a variety of recreational options. The company’s product range includes:

  • Medical Cannabis Offerings: Cultivated under stringent GMP conditions, these products are designed for therapeutic applications and support the treatment protocols of healthcare professionals worldwide.
  • Recreational Cannabis Products: These encompass premium flower selections, pre-rolls, and innovative cannabis extracts that blend tradition with modern consumer preferences.
  • Lifestyle and Consumer Packaged Goods: Tilray’s diversified portfolio includes cannabis-infused beverages, edibles, and wellness products, aimed at providing a holistic experience beyond traditional cannabis consumption.

The company’s research-driven approach is complemented by its integration of quality assurance processes, ensuring that every product is developed with both safety and consistency in mind. This attention to detail demonstrates Tilray’s commitment to maintaining high standards that meet both regulatory demands and consumer expectations.

Commitment to Quality and Innovation

Tilray Brands Inc. emphasizes scientific research and regulatory compliance as fundamental aspects of its operational framework. The GMP-certified cultivation and production facilities underscore the company’s diligent quality control measures, which are critical in establishing trust among patients, physicians, and consumer market segments. The company continuously adapts its methodologies to best meet evolving industry standards, thereby staying ahead in an increasingly competitive landscape.

Competitive Landscape and Differentiation

In a sector marked by rapid innovation and regulatory evolution, Tilray differentiates itself by its robust research capabilities and a commitment to quality manufacturing processes. While many peer companies focus on market share, Tilray prioritizes the development of products that fulfill stringent safety requirements and deliver consistent therapeutic benefits. The company’s diversified product range, spanning both medical and recreational segments, enables it to capture a wide audience and obtain a competitive edge through multifaceted engagement.

Industry Expertise and Strategic Insights

Tilray Brands Inc. leverages deep industry insights and a comprehensive understanding of global regulatory environments to optimize its operations. Its emphasis on scientific research, combined with a diversified business model, underscores the company’s reputation for expertise in product development and market adaptation. For stakeholders seeking detailed analysis of the cannabis and consumer packaged goods sectors, Tilray’s operations offer a rich case study in effective product diversification and regulatory compliance.

Conclusion

Overall, Tilray Brands Inc. presents a well-rounded profile that marries innovation with reliable production processes. Its strategic balance between therapeutic medical cannabis and cutting-edge recreational products positions the company as a pivotal participant in the global cannabis industry. With a focus on quality, safety, and research-backed innovation, Tilray continues to serve as a trusted partner across multiple markets, ensuring its products remain a benchmark of excellence.

Rhea-AI Summary
Manitoba Harvest, a subsidiary of Tilray Brands, Inc., proudly marks a decade as a Certified B Corporation™ with a score of 100, reaffirming its commitment to sustainability and social responsibility. The company's dedication to fostering a positive impact on people and the planet is evident through initiatives like an investment in Regenerative Agriculture.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.44%
Tags
none
-
Rhea-AI Summary
SweetWater Brewing Company, a subsidiary of Tilray Brands, Inc., released two new high-alcohol 'Gummies' brews: Sour Watermelon and Cherry Limeaid India Pale Ales. These fruit-flavored, high-ABV beers are brewed with real fruit and clock in at 9.5% ABV. The company aims to satisfy the demand for full-flavored, high-ABV beers with these new additions to their Gummies lineup, which are now available nationally in major retailers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.76%
Tags
none
-
Rhea-AI Summary
Tilray Brands, Inc. (TLRY) reported a record net revenue of $194 million in Q2 of fiscal year 2024, representing a 34% increase over the prior year period. The company achieved a 31% growth in Canadian cannabis net revenue, and 55% growth in international cannabis net revenue. Tilray also positioned itself as the 5th largest craft beer brewer in the U.S., with a 117% increase in beverage alcohol net revenue. The company aims to achieve $30-$35 million in annual savings related to the integration of HEXO acquisition and has a strong financial liquidity position of ~$261 million. However, the net loss decreased to $46 million, and operating cash flow was $(30) million in the second quarter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.83%
Tags
Rhea-AI Summary
Tilray Brands, Inc. (TLRY) debuts RIFF BOOST™ beverage collection, featuring THC and CBG-infused drinks in two new flavors, Tropical Burst and Vanilla Frost. Each drink contains 10mg THC, 10mg CBG, ginseng extract, and 30mg caffeine from guarana extract. RIFF BOOST is available in 355 mL cans in select regions in Canada.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
none
-
Rhea-AI Summary
Tilray Brands, Inc. (TLRY) to Release Q2 2024 Financial Results on January 9, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
-
Rhea-AI Summary
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) expands its cannabis portfolio with new Chowie Wowie Soft Caramel and Crunchy Praline flavors, alongside its top-selling THC Milk Chocolate and Balanced THC and CBD Milk Chocolate. Chowie Wowie is currently the #2 cannabis infused chocolate brand nationally in Canada, with its Chowie Balanced Milk Chocolate and Chowie THC Milk Chocolate being the top 1 and 2 performing chocolate offerings in the market, and has grown by 12% month over month since May 2023. The new lineup includes Soft Caramel Chocolate with 10mg THC and 10mg CBD and Crunchy Praline Chocolate with 10mg THC and 10mg CBD, both made with premium Belgian chocolate and available across Canada.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
none
Rhea-AI Summary
Alpine Beer, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), announces the return of its renowned ‘Windows Up’ India Pale Ale ('IPA'). The beer features bright tropical and citrus aromas, resiny pine and dank notes, and a 7.5% alcohol by volume. Initially released in 2016, it won the hearts of IPA lovers with its harmonious blending of Mosaic and Citra hops, well balanced by a malt bill of oats and wheat. Windows Up is available in six-packs of 12-ounce cans throughout the Western United States.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.95%
Tags
none
-
Rhea-AI Summary
Breckenridge Distillery (TLRY) Wins Double Gold and Two Gold Awards at the New York International Spirits Competition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.95%
Tags
none
-
Rhea-AI Summary
SweetWater Brewing Company (NASDAQ: TLRY and TSX: TLRY) will celebrate its 27th anniversary on Feb. 17, 2024, with a musical showcase headlined by EarthGang, Daniel Donato's Cosmic Country, and Maddy O'Neal. The event will feature live music performances, special new beers, and a celebration of the brewery's impact on Atlanta's craft beer culture.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.54%
Tags
none
Rhea-AI Summary
Montauk Brewing Company (TLRY) announces the seasonal release of its fan-favorite winter offerings, Cold Day Indian Pale Ale (IPA) and Driftwood Ale. Both are available throughout the Northeast. Cold Day IPA is available in twelve-packs and six-packs 12-ounce cans, 19.2-ounce singles, and on draft. Driftwood Ale is available in six-packs 12-ounce cans and on draft. Cold Day IPA (6.7% ABV) is a slightly hazy India Pale Ale with crisp juicy notes, reminiscent of the invigorating chill of a winter day. Driftwood Ale (6% ABV) is an English Pale Ale and offers a rich malty flavor with hints of toast, nuts, and biscuits.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.85%
Tags
none

FAQ

What is the current stock price of TILRAY BRANDS (TLRY)?

The current stock price of TILRAY BRANDS (TLRY) is $0.45 as of April 17, 2025.

What is the market cap of TILRAY BRANDS (TLRY)?

The market cap of TILRAY BRANDS (TLRY) is approximately 485.3M.

What is Tilray Brands Inc.?

Tilray Brands Inc. is a Canadian-based company that cultivates and supplies both medical and recreational cannabis products, along with a broad portfolio of consumer packaged goods in the wellness and lifestyle segments.

How does Tilray generate revenue?

The company generates revenue through the production and export of high-quality medical cannabis to patients and healthcare institutions, alongside a diversified range of recreational cannabis and lifestyle products distributed in key international markets.

What makes Tilray different from other cannabis companies?

Tilray distinguishes itself through its GMP-certified production facilities, rigorous quality control, research-driven product development, and a diversified product portfolio that caters to both therapeutic and lifestyle needs.

Which markets does Tilray serve?

Tilray operates globally with significant market presence in Canada, Europe, Australia, Latin America, and selected parts of the United States, addressing both regulated medical cannabis exports and domestic consumer markets.

What are the core business segments of Tilray?

Tilray’s core business segments include medical cannabis production, recreational cannabis products, hemp-based food items, and cannabis-infused beverages and wellness products, all unified under a strong research and quality assurance framework.

How does Tilray ensure the quality and safety of its products?

Quality and safety are ensured by using GMP-certified production facilities and maintaining strict quality control measures throughout its research, cultivation, and production processes, aligning with high industry standards and regulatory compliance.
TILRAY BRANDS INC

Nasdaq:TLRY

TLRY Rankings

TLRY Stock Data

485.28M
1.00B
0.65%
11.72%
17.36%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
NEW YORK